American Oncology Network, Inc.

Annual report pursuant to Section 13 or 15(d)

No description available

Completion of Acquisition or Disposition of Assets

Completion of Acquisition or Disposition of Assets

Submission of Matters to a Vote of Security Holders

Notice of Effectiveness

Post Effective Amendment to S-8

Post-effective amendment to a registration statement

Prospectus Supplement for Primary Offering

General form for quarterly reports under Section 13 or 15(d)

Prospectus Supplement for Primary Offering

General form for quarterly reports under Section 13 or 15(d)

Prospectus Supplement for Primary Offering

1.01

5.02

Prospectus Supplement for Primary Offering

Notification of the removal from listing and registration of matured redeemed or retired securities

3.01,9.01

Prospectus Supplement for Primary Offering

Prospectus Supplement for Primary Offering

General form for quarterly reports under Section 13 or 15(d)

2.02,9.01

Prospectus Supplement for Primary Offering

5.02,9.01

Notice of Effectiveness

Annual report pursuant to Section 13 or 15(d) (amendment)

Post-effective amendment to a registration statement

5.02,9.01

7.01,9.01

Annual report pursuant to Section 13 or 15(d)

2.02,9.01

Prospectus Supplement for Primary Offering

Notice of Effectiveness

Correspondence with the SEC

8.01,9.01

Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans

Amended Initial Registration Statement

Correspondence with the SEC

General form for quarterly reports under Section 13 or 15(d)

2.02,9.01

Beneficial ownership report for a holder of more than 5% (Schedule 13D)

Letter from the SEC

5.02

Registration (IPO) statement under Securities Act of 1933

7.01,9.01

06b

Entry into a Material Definitive Agreement

5.02,5.07,8.01

Notification of removal from listing and/or registration on a national securities exchange

8.01,9.01

1.01,2.03,9.01

8.01

General form for quarterly reports under Section 13 or 15(d)

No description available

Correspondence with the SEC

Correspondence with the SEC

Letter from the SEC

No description available

Correspondence with the SEC

Letter from the SEC

Correspondence with the SEC

Letter from the SEC

General form for quarterly reports under Section 13 or 15(d)

Correspondence with the SEC

Annual report pursuant to Section 13 or 15(d)

Additional Information for Proxy Statement/ Votes

Additional Information for Proxy Statement/ Votes

Additional Information for Proxy Statement/ Votes

Definitive Proxy Statement

Additional Information for Proxy Statement/ Votes

No description available

Letter from the SEC

Letter from the SEC

Correspondence with the SEC

Letter from the SEC

Correspondence with the SEC

Preliminary Proxy Statement

Correspondence with the SEC

No description available

Additional Information for Proxy Statement/ Votes

General form for quarterly reports under Section 13 or 15(d)

Definitive Proxy Statement

Additional Information for Proxy Statement/ Votes

General form for quarterly reports under Section 13 or 15(d)

General form for quarterly reports under Section 13 or 15(d)

Notification of late filing of Form 10-Q

Annual report pursuant to Section 13 or 15(d)

Notification of late filing of Form 10-K

General form for quarterly reports under Section 13 or 15(d)

Notification of late filing of Form 10-Q

General form for quarterly reports under Section 13 or 15(d)

Notification of late filing of Form 10-Q

Mallon Erica

Schonherz Todd

Afshar David

Divers Stephen

Fluegel Bradley M

Valle William

Afshar David

Schonherz Todd

Divers Stephen

Valle William

Fluegel Bradley M

Valle William

Divers Stephen

Divers Stephen

Divers Stephen

Divers Stephen

Divers Stephen

Divers Stephen

American Oncology Network, Inc.